Chemed Corp: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Jul 30, 2018 and accepted by EDGAR at Jul 30, 2018, 09:59 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2018-04-01 to 2018-06-30 | $305.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2018-01-01 to 2018-06-30 | $610.3m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2018-04-01 to 2018-06-30 | $68.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2018-01-01 to 2018-06-30 | $137.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | $58.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | $114.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-04-01 to 2018-06-30 | $1.5m | us-gaap:InterestExpense |
| Interest expense | 6 months2018-01-01 to 2018-06-30 | $2.7m | us-gaap:InterestExpense |
| Income tax | 3 months2018-04-01 to 2018-06-30 | $2.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-01-01 to 2018-06-30 | $13.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-04-01 to 2018-06-30 | $55.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | $100.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | $3.27 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | $5.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-04-01 to 2018-06-30 | $3.43 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-01-01 to 2018-06-30 | $6.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-04-01 to 2018-06-30 | 16,811,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-01-01 to 2018-06-30 | 16,854,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | $121.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-01-01 to 2018-06-30 | $23.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2018-01-01 to 2018-06-30 | $9.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2018-01-01 to 2018-06-30 | $84.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-06-30 | $12.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-06-30 | $173.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $928.2m | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $166.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $371.8m | us-gaap:Liabilities |
| Long-term debt | At period end2018-06-30 | $103.4m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2018-06-30 | $556.4m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-06-30 | 16,089,379 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-18-001583. Last ingested by Listed: Nov 5, 2026, 15:55 ET. Listed shows no prices and gives no investment advice.